—
Like Score—qualityScore
PriceFree
Reviews83691% positive
Inbound MLT0peers liking this
Lifetime units—no estimate
StatusLiveVery Positive
LiveStore ↗|Community ↗
Sales estimate not available yet
Free-to-play title. Our sales estimator only covers paid games — F2P revenue (mostly DLC + microtransactions) needs a different methodology.
How sales estimation works →01 Like Score
qualityScore = Σ inbound · log₁₀(reviews+1) · positive% · rank-bonus
Insufficient data
DCBAS
Inbound
0
×
Σ log₁₀(R+1)
—
Avg pos%
—
→ —
02 Top inbound contributors
Games whose “More Like This” lists rank Yu Crossing Animals
No inbound contributors yet · data refreshes daily
03 Yu Crossing Animals’s “More like this”
Outbound MLT · 30 games
Review score
8/ 9
% positive
91.5%cohort 71%
Total reviews
837tracked
Velocity · 30d
1 / dayest
Steam-purchase rate
100.0%flat
01 Language distribution
Reviewer interface language · count, share of total, share positive
21 languages · top 12 shown
ENEnglish62.6%52491%
RURussian10.4%8792%
PTBrazilian Portuguese6.5%5489%
ZHSimplified Chinese5.7%4892%
ESSpanish4.8%4093%
ESLatin American Spanish2.0%17100%
FRFrench1.7%1493%
KOKorean1.1%989%
TWTraditional Chinese1.1%9100%
PLPolish0.8%7100%
ITItalian0.8%7100%
TRTurkish0.5%450%
02 Reviews by playtime
Hours played at time of review · positive% per bucket
0-1h 194
85%positive
1-10h 628
94%positive
10-100h 14
93%positive
100h+ 1
100%positive
03 Monthly timeline
Reviews per month · positive vs negative stacked · since launch
Positive 766Negative 71
1138557280
21·1222·0723·0223·0924·0424·1125·0626·0126·04
04 Breakdowns
Reviews segmented · count, % of total, % positive
837 reviews
Free product
0/ 837
0.0% of total— no data
Early access
0/ 837
0.0% of total— no data
Key activation
0/ 837
0.0% of total— no data
Steam Deck
12/ 837
1.4% of total83% positive
Steam purchase
837/ 837
100.0% of total92% positive
Recommended
766/ 837
91.5% of total— votedUp
Not recommended
71/ 837
8.5% of total— votedDown
Reviews crawled
837/ 837
100.0% of total92% positive
836 reviews · 91% positive
Detailed reviewer overlap is being computed. Check back soon.